FMS Operating Cash Flow (Statement)

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) · Operating Cash Flow (Statement)

FMS logo

FMS Operating Cash Flow (Statement)

Latest reported€2.80B EUR
FMS TTM Cash from Operations · EUR (€416.60M → €2.80B)
High-resolution chart · PNG

FMS operating cash flow (statement) history

Trailing twelve months (TTM) · EUR. Each value covers four complete reported quarters.

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) Operating Cash Flow (Statement) — Trailing twelve months (TTM) (EUR)
Period endingOperating Cash Flow (Statement) (EUR)
2,803,281,364
2,717,912,364
2,653,849,364
2,511,015,000
2,754,167,000
2,421,660,000
2,386,144,000
2,273,508,000
2,048,553,000
2,613,274,000
2,628,801,000
2,509,394,000
2,407,248,000
2,151,517,000
2,167,379,000
2,236,767,000
2,270,838,000
2,440,547,000
2,489,498,000
2,404,636,000
2,458,608,000
3,856,737,000
4,233,156,000
4,419,680,000
4,542,467,000
3,075,459,000
2,566,951,000
2,494,242,000
2,378,802,000
2,182,395,000
2,061,836,000
1,891,836,000
1,750,409,000
1,977,573,000
2,192,169,000
2,466,677,960
2,239,734,863
1,968,939,979
1,957,993,189
1,656,717,909
1,784,533,705
1,501,501,823
1,755,875,149
1,738,189,149
1,817,968,816
1,818,793,313
1,487,419,744
1,405,835,107
1,239,141,422
1,308,910,442
1,473,565,082
1,470,613,590
1,451,741,569
1,427,415,987
1,541,817,094
1,559,593,614
1,516,085,677
1,352,566,465
1,116,033,185
974,247,914
836,709,362
892,832,459
1,028,693,185
1,086,708,299
1,150,676,269
1,077,076,914
934,301,119
823,678,707
786,797,525
725,838,049
730,119,338
706,648,099
702,679,265
732,631,138
822,751,818
945,286,959
806,978,116
765,860,425
687,853,711
541,687,689
600,468,043
592,772,220
565,944,369
550,954,006
544,472,674
578,451,777
610,683,222
617,914,479
625,812,557
623,192,432
598,713,704
555,234,084
539,122,774
557,765,548
524,055,355
592,512,968
551,029,180
469,653,374
476,816,567
433,482,935
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.